Real-world data demonstrate that the MiniMed 780G system effectively controls glucose levels in users who do not administer ...

A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...

Protein and carbohydrate–based insulin dosing doesn't improve glycemic control compared with carbohydrate-based dosing alone in people with type 1 diabetes (T1D). Postprandial glycemic control in ...

Please provide your email address to receive an email when new articles are posted on . Adults with diabetes receiving both basal and bolus insulin through a smart pen miss about six doses every 14 ...

Please provide your email address to receive an email when new articles are posted on . Adults with type 1 diabetes had a higher time in range if they usually administered bolus insulin after a missed ...

COPENHAGEN, Denmark & PALO ALTO, Calif.--(BUSINESS WIRE)--Glooko, Inc. and Hedia today announced the launch of their interoperable solution, which combines connected care, remote patient monitoring, ...

Glooko Inc. and Hedia ApS launched an integrated software solution in the U.K. to support people with diabetes who require advanced doses of bolus insulin. The solution combines Glooko’s diabetes ...

Last month, Roche quietly launched its Accu-Chek Connect app, a diabetes management app which contains, among other things, an unprecented feature: a prescription insulin bolus calculator called Bolus ...